World Market Media's  Instablog

World Market Media
Send Message
GLX - The Global Listing Exchange is a social finance portal to the world’s capital markets. GLX organizes all of the necessary fundamental information and bridges the world’s investment communities giving every member the power to connect, transact and profit.
My company:
World Market Media
My blog:
Straight Talk On SmallCap
  • 3 Pre-Lunch Market Movers - (NASDAQ: IFLG, VRAD, ABIO) 0 comments
    May 17, 2010 12:56 PM | about stocks: VRAD, ABIO

    InfoLogix Inc. (NASDAQ: IFLG) is trading at $11.79 up $5.14 or 17% on heavy volume of 3.8M

    Today, the company announced their plans to collaborate with Samsung Telecommunications America, the No. 1 mobile phone provider in the U.S., on delivering mobile managed services to customers throughout North America.

    Virtual Radiologic Corp. (NASDAQ: VRAD) is trading at $16.92 up $3.93 or 30% on heavy volume of 500k

    Today the company announced it has entered into a definitive agreement to be acquired by Providence Equity Partners. Under the agreement Providence will acquire all of the outstanding common stock of vRad for $17.25 per share in cash. The offer price represents a premium of 41.7% over the 30-day average closing stock price of $12.18 as of May 14, 2010, and a premium of 54.9% over the three month average closing stock price of $11.13. Based on the per share consideration, the transaction is valued at approximately $294 million.

    ARCA biopharma Inc. (NASDAQ: ABIO) is trading at $5.10 up $0.83 or 19% on heavy volume of 2.8M

    Today the company announced that it has reached agreement with the FDA regarding a Special Protocol Assessment (NYSE:SPA) on the design of a clinical trial to assess the safety and efficacy of bucindolol in approximately 3,200 patients with chronic heart failure who have the genotype that appears to respond most favorably to bucindolol. Bucindolol is the Company's investigational, pharmacologically unique, beta-blocker and mild vasodilator. An SPA is an agreement with the FDA that the proposed trial protocol design, clinical endpoints and statistical analyses are acceptable to support regulatory approval.

    Disclosure: no positions
    Stocks: VRAD, ABIO
Back To World Market Media's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.